Hannah Sophia is a scientist (PhD chemist) and health economist with cross sector experience on innovative technologies that include novel drug delivery, AI and the human digital twin, CNS disorders and longevity.

She works in all areas of innovation from R&D through to IP, Regulatory, Market Access and Commercialisation. As keynote speaker she has been invited to deliver lectures on innovation, human augmentation and other topics.

Dr Sophia is an active member of a number of advisory boards for innovation including the Standing Advisory Committee before the European Patent Office and the British Army Health Sector Advisory Group.